RNAO’s continuing media profile: The June report

This month, RNAO spoke out on a number of prominent issues in the media including COVID-19 vaccinations, the province’s reopening framework, the ineffectiveness of signing bonuses for new staff, the urgency to repeal Bill 124, and the welcoming of Ontario’s new Chief Medical Officer of Health Dr. Kieran Moore.

The world is at risk of 'vaccine apartheid'

This week we consider the shocking status of vaccine inequity from a global perspective. World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus said recently that the world is at risk of 'vaccine apartheid'. The WHO chief highlighted that at least 63 million doses of vaccines have been shipped to 124 countries and economies, but they represent just 0.5 per cent of the combined population of those nations. He also noted that the basic problem of vaccine inequity was a lack of sharing by the wealthy countries that have accumulated most of the vaccine supplies.

Canada is virtue signalling while waffling on global access to COVID-19 vaccines

This article addresses the shocking contrast between Canada's declarations of concern with the global distribution of vaccines, and the poor reality of its actions. Joel Lexchin, Professor Emeritus of Health Policy and Management, York University, Emergency Physician at University Health Network, Associate Professor of Family and Community Medicine, University of Toronto tackles this question.

Global herd immunity remains out of reach because of inequitable vaccine distribution – 99% of people in poor countries are unvaccinated

As we reach enormously successful levels of COVID-19 inoculation in Canada and other rich countries, the disparities with the rest of the world become starker. This article considers the enormous cost in lives of leaving most of the global population unvaccinated. It draws lessons on how we can do better from the effort to provide lifesaving drugs for HIV-AIDS in the 1990s. This June 22 article is by Maria De Jesus, Associate Professor and Research Fellow at the Center on Health, Risk, and Society, American University School of International Service.

AstraZeneca second dose: Should I get the same vaccine or choose Pfizer or Moderna?

 • 
Ontarians have received about 900,000 doses of the AstraZeneca vaccine, mostly as a first dose. These Ontarians now have the choice of getting a second dose of the AstraZeneca or an mRNA vaccine. The following article, addressing the question of which one they should choose, is from Alexander Wong, an associate professor of infectious diseases at the University of Saskatchewan.

RNAO’s continuing media profile: The May report

RNAO continues to be active in the media to keep nurses, other health providers and the public informed of our views and advise during these challenging times. This month, we spoke out on many important issues, including long-term care (LTC), vaccinations, nurse burnout and the measures required to bring an end to the pandemic.

Vaccination passport apps could help society reopen – first they have to be secure, private and trusted

Vaccine passports may become unavoidable as we gradually move out of the pandemic. RNAO supports the use of one if it is designed in the proper way, given the serious concerns about equity, safety and privacy. We started the conversation before and now continue with an article published March 23 by Laurin Weissinger, a lecturer in cybersecurity at Tufts University.